By Professor Graham Jones

Book Chapters

Jones G, 2012, 'Towards a national chronic kidney disease testing program', in Advances in Clinical Chemistry and Laboratory Medicine, pp. 75 - 77

Jones G, 2012, 'Unmet needs in chronic kidney disease testing', in Advances in Clinical Chemistry and Laboratory Medicine, pp. 72 - 74

Journal articles

Farrell CJL; Jones GRD; Sikaris KA; Badrick T; Graham P; Bush J, 2024, 'Sharing reference intervals and monitoring patients across laboratories – findings from a likely commutable external quality assurance program', Clinical Chemistry and Laboratory Medicine, http://dx.doi.org/10.1515/cclm-2024-0041

Kanis JA; Johansson H; McCloskey EV; Liu E; Åkesson KE; Anderson FA; Azagra R; Bager CL; Beaudart C; Bischoff-Ferrari HA; Biver E; Bruyère O; Cauley JA; Center JR; Chapurlat R; Christiansen C; Cooper C; Crandall CJ; Cummings SR; da Silva JAP; Dawson-Hughes B; Diez-Perez A; Dufour AB; Eisman JA; Elders PJM; Ferrari S; Fujita Y; Fujiwara S; Glüer CC; Goldshtein I; Goltzman D; Gudnason V; Hall J; Hans D; Hoff M; Hollick RJ; Huisman M; Iki M; Ish-Shalom S; Jones G; Karlsson MK; Khosla S; Kiel DP; Koh WP; Koromani F; Kotowicz MA; Kröger H; Kwok T; Lamy O; Langhammer A; Larijani B; Lippuner K; Mellström D; Merlijn T; Nordström A; Nordström P; O’Neill TW; Obermayer-Pietsch B; Ohlsson C; Orwoll ES; Pasco JA; Rivadeneira F; Schott AM; Shiroma EJ; Siggeirsdottir K; Simonsick EM; Sornay-Rendu E; Sund R; Swart KMA; Szulc P; Tamaki J; Torgerson DJ; van Schoor NM; van Staa TP; Vila J; Wareham NJ; Wright NC; Yoshimura N; Zillikens MC; Zwart M; Vandenput L; Harvey NC; Lorentzon M; Leslie WD, 2023, 'Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX', Osteoporosis International, 34, pp. 2027 - 2045, http://dx.doi.org/10.1007/s00198-023-06870-z

Farrell CJ; Jones G; Shepherd S; Tran D; Badrick T, 2023, 'Mass or molar units? Australia's drug problem persists', Pathology, 55, pp. 865 - 867, http://dx.doi.org/10.1016/j.pathol.2023.03.006

Jamieson EL; Dimeski G; Flatman R; Hickman PE; Ross Dallas Jones G; V Marley J; David McIntyre H; McNeil AR; Nolan CJ; Potter JM; Sweeting A; Ward P; Williams P; Rita Horvath A, 2023, 'Oral glucose tolerance test to diagnose gestational diabetes mellitus: Impact of variations in specimen handling', Clinical Biochemistry, 115, pp. 33 - 48, http://dx.doi.org/10.1016/j.clinbiochem.2022.10.002

Haeckel R; Adeli K; Jones G; Sikaris K; Wosniok W, 2023, 'Definitions and major prerequisites of direct and indirect approaches for estimating reference limits', Clinical Chemistry and Laboratory Medicine, 61, pp. 402 - 406, http://dx.doi.org/10.1515/cclm-2022-1061

Handelsman DJ; Jones G; Kouzios D; Desai R, 2023, 'Evaluation of testosterone, estradiol and progesterone immunoassay calibrators by liquid chromatography mass spectrometry', Clinical Chemistry and Laboratory Medicine, http://dx.doi.org/10.1515/cclm-2022-1179

Jones G; Farrell C; Sikaris K; Shepherd S; Bush J; Badrick T, 2023, 'Australia as one big laboratory – are our results good enough?', Pathology, 55, pp. S8 - S9, http://dx.doi.org/10.1016/j.pathol.2022.12.034

Radovanovic M; Day RO; Jones GDR; Galettis P; Norris RLG, 2022, 'LC–MS/MS method for simultaneous quantification of ten antibiotics in human plasma for routine therapeutic drug monitoring', Journal of Mass Spectrometry and Advances in the Clinical Lab, 26, pp. 48 - 59, http://dx.doi.org/10.1016/j.jmsacl.2022.11.001

Badrick T; Jones G; Miller WG; Panteghini M; Quintenz A; Sandberg S; Spannagl M, 2022, 'Differences between Educational and Regulatory External Quality Assurance/Proficiency Testing Schemes', Clinical Chemistry, 68, pp. 1238 - 1244, http://dx.doi.org/10.1093/clinchem/hvac132

Tickell AM; Rohleder C; Ho N; McHugh C; Jones G; Song YJC; Hickie IB; Scott EM, 2022, 'Identifying pathways to early-onset metabolic dysfunction, insulin resistance and inflammation in young adult inpatients with emerging affective and major mood disorders', Early Intervention in Psychiatry, 16, pp. 1121 - 1129, http://dx.doi.org/10.1111/eip.13260

Thomas DH; Warner JV; Jones GRD; Chung JZY; MacEy DJ; Screnci A; Ryan JB, 2022, 'Total bilirubin assay differences may cause inconsistent treatment decisions in neonatal hyperbilirubinaemia', Clinical Chemistry and Laboratory Medicine, 60, pp. 1736 - 1744, http://dx.doi.org/10.1515/cclm-2022-0749

Jones GRD; Chung JZY, 2022, 'The effect of acute changes in glomerular filtration rate on common biochemical tests', Practical Laboratory Medicine, 31, http://dx.doi.org/10.1016/j.plabm.2022.e00280

Badrick T; Miller WG; Panteghini M; Delatour V; Berghall H; MacKenzie F; Jones G, 2022, 'Interpreting EQA - Understanding Why Commutability of Materials Matters', Clinical Chemistry, 68, pp. 494 - 500, http://dx.doi.org/10.1093/clinchem/hvac002

Jones GRD; Delatour V; Badrick T, 2022, 'Metrological traceability and clinical traceability of laboratory results-the role of commutability in External Quality Assurance', Clinical Chemistry and Laboratory Medicine, 60, pp. 669 - 674, http://dx.doi.org/10.1515/cclm-2022-0038

Radovanovic M; Jones G; Day RO; Galettis P; Norris RLG, 2022, 'Mitigating analyte to stable isotope labelled internal standard cross-signal contribution in quantitative liquid chromatography-tandem mass spectrometry', Journal of Mass Spectrometry and Advances in the Clinical Lab, 24, pp. 57 - 64, http://dx.doi.org/10.1016/j.jmsacl.2022.04.002

Reuter SE; Stocker SL; Alffenaar JWC; Baldelli S; Cattaneo D; Jones G; Koch BCP; Kocic D; Mathew SK; Molinaro M; Neely M; Sandaradura I; Marriott DJE, 2022, 'Optimal Practice for Vancomycin Therapeutic Drug Monitoring: Position Statement from the Anti-infectives Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology', Therapeutic Drug Monitoring, 44, pp. 121 - 132, http://dx.doi.org/10.1097/FTD.0000000000000944

Wong S; Reuter SE; Jones GRD; Stocker SL, 2022, 'Review and evaluation of vancomycin dosing guidelines for obese individuals', Expert Opinion on Drug Metabolism and Toxicology, 18, pp. 323 - 335, http://dx.doi.org/10.1080/17425255.2022.2098106

Roberts DM; Hughes HK; Haber PS; Jones GRD, 2022, 'Variability in insulin pharmacokinetics following high-dose insulin therapy', Clinical Toxicology, 60, pp. 389 - 391, http://dx.doi.org/10.1080/15563650.2021.1967372

Loh TP; Smith AF; Bell KJL; Lord SJ; Ceriotti F; Jones G; Bossuyt P; Sandberg S; Horvath AR, 2021, 'Setting analytical performance specifications using HbA1c as a model measurand', Clinica Chimica Acta, 523, pp. 407 - 414, http://dx.doi.org/10.1016/j.cca.2021.10.016

El-Khoury JM; Hoenig MP; Jones GRD; Lamb EJ; Parikh CR; Tolan NV; Wilson FP, 2021, 'AACC Guidance Document on Laboratory Investigation of Acute Kidney Injury', Journal of Applied Laboratory Medicine, 6, pp. 1316 - 1337, http://dx.doi.org/10.1093/jalm/jfab020

Ozarda Y; Ichihara K; Jones G; Streichert T; Ahmadian R, 2021, 'Comparison of reference intervals derived by direct and indirect methods based on compatible datasets obtained in Turkey', Clinica Chimica Acta, 520, pp. 186 - 195, http://dx.doi.org/10.1016/j.cca.2021.05.030

Imani S; Buscher H; Day R; Gentili S; Jones GRD; Marriott D; Norris R; Sandaradura I, 2021, 'Correction to: An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy (European Journal of Clinical Microbiology & Infectious Diseases, (2018), 37, 11, (2171-2175), 10.1007/s10096-018-3357-9)', European Journal of Clinical Microbiology and Infectious Diseases, 40, pp. 1789, http://dx.doi.org/10.1007/s10096-021-04291-6

Patel K; El-Khoury JM; Aarsand AK; Badrick T; Jones GRD; Sikaris K; Parnas ML, 2021, 'Current Utility and Reliability of Biological Variability', Clinical Chemistry, 67, pp. 1050 - 1055, http://dx.doi.org/10.1093/clinchem/hvab055

Cunio CB; Uster DW; Carland JE; Buscher H; Liu Z; Brett J; Stefani M; Jones GRD; Day RO; Wicha SG; Stocker SL, 2021, 'Towards precision dosing of vancomycin in critically ill patients: an evaluation of the predictive performance of pharmacometric models in ICU patients', Clinical Microbiology and Infection, 27, pp. 783.e7 - 783.e14, http://dx.doi.org/10.1016/j.cmi.2020.07.005

El-Khoury JM; Ovalle AA; Cervinski MA; Levey AS; Jones G; Eneanya ND; Lieske JC; Jha V, 2021, 'Is It Time to Move On? Reexamining Race in Glomerular Filtration Rate Equations', Clinical Chemistry, 67, pp. 585 - 591, http://dx.doi.org/10.1093/clinchem/hvaa333

Sikaris K; Koerbin G; Jones G; Flatman R, 2021, 'Reply to Dr Hawkins regarding comparability of results for monitoring', Clinical Chemistry and Laboratory Medicine, 59, pp. E221 - E222, http://dx.doi.org/10.1515/cclm-2020-0604

Mukerji S; Jones GRD, 2021, 'Uncertainty should not be neglected in potassium correction for haemolysis', Scandinavian Journal of Clinical and Laboratory Investigation, 81, pp. 423, http://dx.doi.org/10.1080/00365513.2021.1931710

Muir CA; Jones GRD; Greenfield JR; Weissberger A; Samaras K, 2020, 'THYROID PEROXIDASE ANTIBODY POSITIVITY IS ASSOCIATED with RELAPSE-FREE SURVIVAL following ANTITHYROID DRUG TREATMENT for GRAVES DISEASE', Endocrine Practice, 26, pp. 1026 - 1030, http://dx.doi.org/10.4158/EP-2020-0035

Badve SV; Pascoe EM; Tiku A; Boudville N; Brown FG; Cass A; Clarke P; Dalbeth N; Day RO; De Zoysa JR; Douglas B; Faull R; Harris DC; Hawley CM; Jones GRD; Kanellis J; Palmer SC; Perkovic V; Rangan GK; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW; Neal B, 2020, 'Effects of allopurinol on the progression of chronic kidney disease', New England Journal of Medicine, 382, pp. 2504 - 2513, http://dx.doi.org/10.1056/NEJMoa1915833

Muir CA; Greenfield JR; Weissberger A; Jones GRD; Samaras K, 2020, 'SAT-LB75 Thyroid Peroxidase Antibody Positivity Predicts Relapse Free Survival Following Anti-Thyroid Drug Treatment for Graves Disease', Journal of the Endocrine Society, 4, http://dx.doi.org/10.1210/jendso/bvaa046.2016

Wan KL; Boscato L; Jones GRD; Brown J; Lu ZX; Doery JCG, 2020, 'A curious family of stunted growth', Pathology, 52, pp. S100 - S100, http://dx.doi.org/10.1016/j.pathol.2020.01.342

Ekinci EI; Barr ELM; Barzi F; Hughes JT; Lawton PD; Jones GRD; Hoy W; Cass A; Thomas M; Sinha A; Jerums G; O'Dea K; MacIsaac RJ; Maple-Brown LJ, 2019, 'Is hyperfiltration associated with higher urine albumin-to-creatinine ratio at follow up among Indigenous Australians? The eGFR follow-up study', Journal of Diabetes and its Complications, 33, pp. 343 - 349, http://dx.doi.org/10.1016/j.jdiacomp.2019.02.005

Jones GRD, 2019, 'Estimates of within-subject biological variation derived from pathology databases: An approach to allow assessment of the effects of age, sex, time between sample collections, and analyte concentration on reference change values', Clinical Chemistry, 65, pp. 579 - 588, http://dx.doi.org/10.1373/clinchem.2018.290841

Koerbin G; Sikaris K; Jones GRD; Flatman R; Tate JR, 2019, 'An update report on the harmonization of adult reference intervals in Australasia', CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 57, pp. 38 - 41, http://dx.doi.org/10.1515/cclm-2017-0920

Jones GRD; Haeckel R; Loh TP; Sikaris K; Streichert T; Katayev A; Barth JH; Ozarda Y, 2019, 'Indirect methods for reference interval determination - review and recommendations', CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 57, pp. 20 - 29, http://dx.doi.org/10.1515/cclm-2018-0073

Greg Miller MW; Bachmann LM; Delanghe JR; Inker LA; Jones GRD; Vassalotti JA, 2019, 'Optimal use of biomarkers for chronic kidney disease', Clinical Chemistry, 65, pp. 949 - 955, http://dx.doi.org/10.1373/clinchem.2018.299073

Jones GRD; Legg M, 2019, 'Report formatting in laboratory medicine - a call for harmony', CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 57, pp. 61 - 65, http://dx.doi.org/10.1515/cclm-2017-1165

de Leon R; James B; Jones G; Calleja J; San Gil F; Choy KW; Graham P, 2019, 'Introduction of a body fluids external quality assurance program', Pathology, 51, pp. S18 - S18, http://dx.doi.org/10.1016/j.pathol.2018.12.039

Dahm MR; Georgiou A; Herkes R; Brown A; Li J; Lindeman R; Horvath AR; Jones G; Legg M; Li L; Greenfield D; Westbrook JI, 2018, 'Patient groups, clinicians and healthcare professionals agree - All test results need to be seen, understood and followed up', Diagnosis, 5, pp. 215 - 222, http://dx.doi.org/10.1515/dx-2018-0083

Imani S; Buscher H; Day R; Gentili S; Jones GRD; Marriott D; Norris R; Sandaradura I, 2018, 'An evaluation of risk factors to predict target concentration non-attainment in critically ill patients prior to empiric β-lactam therapy', European Journal of Clinical Microbiology and Infectious Diseases, 37, pp. 2171 - 2175, http://dx.doi.org/10.1007/s10096-018-3357-9

Barr ELM; Barzi F; Hughes JT; Jerums G; O'Dea K; Brown ADH; Ekinci EI; Jones GRD; Lawton PD; Sinha A; MacIsaac RJ; Cass A; Maple-Brown LJ, 2018, 'Contribution of cardiometabolic risk factors to estimated glomerular filtration rate decline in Indigenous Australians with and without albuminuria - the eGFR Follow-up Study', Nephrology, 23, pp. 682 - 689, http://dx.doi.org/10.1111/nep.13073

Koerbin G; Sikaris K; Jones GRD; Tate JR, 2018, 'Urea: another analyte recommended for harmonised reference intervals', Pathology, 50, pp. 461 - 462, http://dx.doi.org/10.1016/j.pathol.2017.10.025

Barr ELM; Barzi F; Hughes JT; Jerums G; Hoy WE; O'Dea K; Jones GRD; Lawton PD; Brown ADH; Thomas M; Ekinci EI; Sinha A; Cass A; MacIsaac RJ; Maple-Brown LJ, 2018, 'High baseline levels of tumor necrosis factor receptor 1 are associated with progression of kidney disease in indigenous australians with diabetes: The eGFR follow-up study', Diabetes Care, 41, pp. 739 - 747, http://dx.doi.org/10.2337/dc17-1919

Barzi F; Jones GRD; Hughes JT; Lawton PD; Hoy W; O'Dea K; Jerums G; MacIsaac RJ; Cass A; Maple-Brown LJ, 2018, 'Trajectories of eGFR decline over a four year period in an Indigenous Australian population at high risk of CKD-the eGFR follow up study', Clinical Biochemistry, 53, pp. 58 - 64, http://dx.doi.org/10.1016/j.clinbiochem.2018.01.011

Dahm MR; Georgiou A; Westbrook JI; Greenfield D; Horvath AR; Wakefield D; Li L; Hillman K; Bolton P; Brown A; Jones G; Herkes R; Lindeman R; Legg M; Makeham M; Moses D; Badmus D; Campbell C; Hardie RA; Li J; McCaughey E; Sezgin G; Thomas J; Wabe N, 2018, 'Delivering safe and effective test-result communication, management and follow-up: A mixed-methods study protocol', BMJ Open, 8, pp. e020235, http://dx.doi.org/10.1136/bmjopen-2017-020235

Dadlani N; Farrar A; Jones G, 2018, 'Variability amongst urine toxicology amphetamine readings with concurrent administration of fenofibrate', Australasian Psychiatry, 26, pp. 24 - 26, http://dx.doi.org/10.1177/1039856217715991

Hughes JT; Maple-Brown LJ; Thomas M; Lawton PD; Sinha A; Cass A; Barzi F; Jones GRD; Jerums G; MacIsaac RJ; O'Dea K; Hoy WE, 2018, 'Cross-sectional associations of albuminuria among Aboriginal and Torres Strait Islander adults: the eGFR Study', NEPHROLOGY, 23, pp. 37 - 45, http://dx.doi.org/10.1111/nep.12956

Miller WG; Jones GRD, 2018, 'Estimated Glomerular Filtration Rate; Laboratory Implementation and Current Global Status', Advances in Chronic Kidney Disease, 25, pp. 7 - 13, http://dx.doi.org/10.1053/j.ackd.2017.09.013

Back to profile page